Safety and efficacy of port use for CAR T-cell infusion in large B-cell lymphoma

• by Zachary E. Hunzeker, Anath Lionel, Xiaowen Sun, Lei Feng, Sairah Ahmed, Amy Ayers, Michelly de Castro, Jaimole Varghese, Karla Ow, Taylor Cain, Minifrida Santiago, Sreekala Nair, Jeremy Ramdial, Elizabeth J. Shpall, Sattva S. Neelapu, Paolo Strati

• October 28, 2026

Engineering a New Generation of Cancer-Fighting Cells

USC researchers develop a scalable cell engineering platform that could overcome key manufacturing and therapeutic limitations of CAR-based immunotherapies

• October 28, 2026

• 3 min

Naive-Like T Cells Linked to CAR T Durability

Higher proportions of less-differentiated T cells were associated with longer progression-free survival in a 783-patient lymphoma analysis

• November 4, 2026

• 3 min

Error in Number of Cancers

• October 27, 2026